Search research articles
Contact Us
Filters
Showing results (411-420 of 419) with videos related to
Page
of 42
Sort By:
You have reached the last page of results.
This site can display upto 419 results.
World Journal of Emergency Surgery : WJES
|
June 8, 2024
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use
Massimo Sartelli, Carlo Tascini, Federico Coccolini, et al.
Journal for Immunotherapy of Cancer
|
April 8, 2021
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini, Massimo Di Maio, Olga Nigro, et al.
Jac-Antimicrobial Resistance
|
October 8, 2025
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study
Daniele Roberto Giacobbe, Claudia Bartalucci, Martina Bavastro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
The European Physical Journal. C, Particles and Fields
|
November 10, 2025
Bayesian network 3D event reconstruction in the Cygno optical TPC for dark matter direct detection
Fernando Domingues Amaro, Rita Antonietti, Elisabetta Baracchini, et al.
The European Physical Journal. C, Particles and Fields
|
October 31, 2024
Enhancing the light yield of He:CF <math></math> based gaseous detector
Fernando Domingues Amaro, Rita Antonietti, Elisabetta Baracchini, et al.
The Journal of Infection
|
April 4, 2026
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremia
Alessandro Russo, Sara Palma Gullì, Antonio Vena, et al.
Journal for Immunotherapy of Cancer
|
February 4, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, et al.
Page
of 42
Search research articles
Search
Showing results (411-420 of 419) with videos related to
Sort By:
Page
of 42
You have reached the last page of results.
This site can display upto 419 results.
World Journal of Emergency Surgery : WJES
|
June 8, 2024
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use
Massimo Sartelli, Carlo Tascini, Federico Coccolini, et al.
Journal for Immunotherapy of Cancer
|
April 8, 2021
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Alessio Cortellini, Massimo Di Maio, Olga Nigro, et al.
Jac-Antimicrobial Resistance
|
October 8, 2025
Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study
Daniele Roberto Giacobbe, Claudia Bartalucci, Martina Bavastro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2021
Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy
Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone, et al.
The European Physical Journal. C, Particles and Fields
|
November 10, 2025
Bayesian network 3D event reconstruction in the Cygno optical TPC for dark matter direct detection
Fernando Domingues Amaro, Rita Antonietti, Elisabetta Baracchini, et al.
The European Physical Journal. C, Particles and Fields
|
October 31, 2024
Enhancing the light yield of He:CF <math></math> based gaseous detector
Fernando Domingues Amaro, Rita Antonietti, Elisabetta Baracchini, et al.
The Journal of Infection
|
April 4, 2026
Predictors of mortality and therapeutic efficacy in carbapenem-resistant Acinetobacter baumannii bacteremia
Alessandro Russo, Sara Palma Gullì, Antonio Vena, et al.
Journal for Immunotherapy of Cancer
|
February 4, 2025
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, et al.
Journal for Immunotherapy of Cancer
|
September 29, 2025
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, et al.
Page
of 42